Exact Sciences Corporation - Investor Relations - Financial Information - Quarterly Results. Exact Sciences Corporation EXAS CEO Kevin Conroy on Q3 2021 Results -.
What Do Exact Sciences New Risk Factors Tell Investors Nasdaq
Exact Sciences which belongs to the Zacks Medical - Biomedical and Genetics industry posted revenues of 45638 million for the quarter ended September 2021.
Exact sciences quarterly earnings report. Exact Sciences last released its earnings data on November 1st 2021. The medical research company reported 097 EPS for the quarter missing the Zacks consensus estimate of 089 by 008. New Senior Vice President Bill Megan who joined the company during the third quarter said the company used 10 million in cash and ended the quarter with a cash balance of 148 million.
However the metric lagged the Zacks. Exact Sciences reported second-quarter 2021 net loss of 103 significantly wider than net loss of 45 cents in the year-ago period and the Zacks Consensus Estimate of a loss of 72 cents per share. Exact Sciences NASDAQEXAS last posted its quarterly earnings results on Monday November 1st.
EXAS today announced that the company generated revenue of 4564. MADISON Wis July 28 2021 PRNewswire -- Exact Sciences Corp. EXAS today announced that the company generated revenue of 4348.
Exact Sciences Cor EXAS reports earnings on 212022. AP _ Exact Sciences Corp. For the last reported quarter it was expected that Exact Sciences would post a loss of 072 per share when it actually produced a loss of 103 delivering a surprise of -4306.
EXACT Sciences is reporting latest earnings on May 4. Exact Sciences Corporation 2021 Q3 - Results - Earnings Call Presentation. The medical research company reported 097 earnings per share for the quarter missing the consensus estimate of 089 by 008.
EXAS today announced that the company plans to release its first quarter 2021 financial results after the close of the US. Conroy shared that Exact Sciences has responded to questions. EXAS today announced that the company generated revenue of 4348.
Shares are down 56 since reporting last quarter. 10068 Find current average PE ratios for all sectors below EXAS Upcoming Earnings. -2137 Price Nov 05 2021 EOD.
MADISON Wis April 8 2021 PRNewswire -- Exact Sciences Corp. The business earned 45638 million during the quarter compared to analysts expectations of 42904 million. Exact Sciences Corporation EXAS reported third-quarter 2021 net loss of 97 cents significantly narrower than net loss of 135 in the year-ago period.
The companys total revenue came in at 2956 million just over double the 1249 million reported back in Q4 2018. EXAS on Tuesday reported a loss of 1669 million in its third quarter. MADISON Wis July 28 2021 PRNewswire -- Exact Sciences Corp.
Exact Sciences reported second-quarter 2021 net loss of 103 significantly wider than net loss of 45 cents in the year-ago period and the Zacks Consensus Estimate of a loss of 72 cents per share. Exact Sciences Corporation EXAS is slated to report fourth-quarter 2020 results on Feb 16 after the closing bell. Exact Sciences had a negative net margin of 4614 and a negative return on equity of 1163.
Financial markets on May 4 2021. Do the numbers hold. MADISON Wis Nov.
Exact Sciences Announces Second Quarter 2021 Results. Despite strong top-line improvement a significant surge in operating expenses led to the bottom-line debacle in the reported quarter. EXACT Sciences Corporation Stock Earnings Report NASDAQEXAS Current PE ratio.
Exact Sciences schedules first quarter 2021 earnings call. The Earnings Whisper Score gives the statistical odds for the stock ahead of. While Exact Sciences reported a profit of 779 million for the quarter it.
Exact Sciences Corporation EXAS latest earnings report. In the last-reported quarter the companys loss per share of 36 cents was narrower than the Zacks Consensus Estimate of a loss of 51 cents per share. 2 2021 PRNewswire -- Exact Sciences Corp.
Exact Sciences Corporation EXAS reported third-quarter 2021 net loss of 97 cents significantly narrower than net loss of 135 in the year-ago period. Earnings ESP Expected Surprise Prediction is Zacks proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. Revenue EPS surprise history news and analysis.
Exact Sciences EXAS delivered earnings and revenue surprises of -4306 and 384 respectively for the quarter ended June 2021. Wall Street predict expect EXACT Sciences will report losses per share of 0964.
Exact Sciences Exas To Release Earnings On Tuesday Marketbeat
Exact Sciences Announces Third Quarter 2021 Results
Club Corp Ir Financials Web Site Development Financial Information Financial